Stock Code: 002424 Stock Abbreviation: ST Bai Ling Announcement No.: 2026-037 Guizhou Bai Ling Pharmaceutical Group Co., Ltd. Announcement on Approval of First Traditional Chinese Medicine Class II Protected Variety
The Company and all members of the Board of Directors guarantee the content of the information disclosed is true, accurate, and complete, and that there are no false records, misleading statements, or major omissions.
Recently, the National Medical Products Administration (hereinafter referred to as the "National Medical Products Administration") website released the "Announcement on Protected Chinese Medicine Varieties (No. 36) (2026 No. 44)". In accordance with the "Regulations on the Protection of Chinese Medicine Varieties", Guizhou Bai Ling Pharmaceutical Group Co., Ltd.'s Compound Artemisia Scoparia Spray has been approved as the first Traditional Chinese Medicine Class II Protected Variety. The protection variety number is ZYB2072026013, and the protection period is seven years from the date of announcement.
As a key Miao medicine product cultivated by Guizhou Bai Ling, the Compound Artemisia Scoparia Spray has the following indications: Miao Medicine: Xu Ga Kai Ta Jia, Xie Zhang Jie Kai, Xu Ga Yi Jie Hong. Dong: Meng Kui Gao. Na Meng Ning Jia, Mi Luo La Mi, Mu Ga Guo Yu, Luo Xiang. Traditional Chinese Medicine: Clearing heat and detoxifying, dispersing wind-heat, clearing and benefiting the throat. It is used for upper respiratory tract infections, acute and chronic pharyngitis, mouth and tongue sores, gum swelling and pain, and bad breath. Compound Artemisia Scoparia Spray was approved by the National Medical Products Administration in March 2026, expanding the main indication population for acute pharyngitis to "children aged 6-13 years".